The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $73.70

Today's change+0.50 +0.68%
Updated September 3 4:03 PM EDT. Delayed by at least 15 minutes.
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $73.70

Today's change+0.50 +0.68%
Updated September 3 4:03 PM EDT. Delayed by at least 15 minutes.

Molina Healthcare Inc up (U.S.)$0.50

Molina Healthcare Inc closed up Thursday by (U.S.)$0.50 or 0.68% to (U.S.)$73.70. Shares have lost 3.12% over the last five days, but have gained 37.68% over the last year to date. This security has outperformed the S&P 500 by 62.59% during the last year.

Key company metrics

  • Open(U.S.) $73.20
  • Previous close(U.S.) $73.20
  • High(U.S.) $74.91
  • Low(U.S.) $73.12
  • Bid / Ask-- / --
  • YTD % change+37.68%
  • Volume625,579
  • Average volume (10-day)949,609
  • Average volume (1-month)942,830
  • Average volume (3-month)1,022,610
  • 52-week range(U.S.) $40.79 to (U.S.) $82.37
  • Beta2.05
  • Trailing P/E31.25×
  • P/E 1 year forward27.81×
  • Forward PEG0.70×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.36
Updated September 3 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.98%

Based on its net profit margin of 0.98%, Molina Healthcare Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue3,5253,1712,8012,484
Total other revenue--------
Total revenue3,5253,1712,8012,484
Gross profit563499439346
Total cost of revenue2,9622,6722,3612,138
Total operating expense3,4093,0892,7052,445
Selling / general / administrative422392318282
Research & development--------
Depreciation / amortization25252524
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income116829640
Interest income (expense), net non-operating-15-15-15-14
Gain (loss) on sale of assets--------
Other--------
Income before tax101678224
Income after tax39283416
Income tax, total6239488
Net income39283416
Total adjustments to net income--------
Net income before extra. items39283416
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items39283416
Inc. avail. to common incl. extra. items39283416
Diluted net income39283416
Dilution adjustment------0
Diluted weighted average shares50504949
Diluted EPS excluding extraordinary itemsvalue per share0.770.560.690.33
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.770.560.690.33